Literature DB >> 28770296

A systematic review on vaginal laser therapy for treating stress urinary incontinence: Do we have enough evidence?

Vasilios Pergialiotis1, Anastasia Prodromidou2, Despina N Perrea2, Stergios K Doumouchtsis2,3.   

Abstract

INTRODUCTION AND HYPOTHESIS: Current treatment strategies for stress urinary incontinence (SUI) raise concerns about safety and efficacy. The purpose of this systematic review was to present available evidence related to vaginal laser therapy as a treatment option for SUI.
METHODS: We searched the MEDLINE (1966-2017), Scopus (2004-2017), Clinicaltrials.gov (2008-2017) and Cochrane Central Register of Controlled Trials (CENTRAL) (1999-2017) databases for relevant studies in this field. We aimed to include all observational studies (prospective and retrospective, randomized and nonrandomized) that reported outcomes on vaginal laser therapy as a treatment option for SUI.
RESULTS: Thirteen studies were included that recruited 818 patients who underwent laser therapy for SUI. The methodological quality of most included studies was low, as they were either individual case-control studies, case series or poor-quality cohorts (Oxford Level of Evidence 3b and 4). According to the existing evidence, laser therapy may be a useful, minimally invasive approach for treating SUI. However, the methodological limitations of included studies render them prone to significant bias, limiting their scientific integrity.
CONCLUSIONS: As the demand for minimally invasive approaches for treating SUI increases, it is expected that more patients will seek alternative treatments over current standards (midurethral slings). Given the limitations of the existing studies, it seems that conducting future trials is necessary to elucidate this field.

Entities:  

Keywords:  Erbium; Incontinence; Laser; Sui; Systematic review

Mesh:

Year:  2017        PMID: 28770296     DOI: 10.1007/s00192-017-3437-x

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  23 in total

1.  Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function.

Authors:  Yi-Wen Tien; Sheng-Mou Hsiao; Chien-Nan Lee; Ho-Hsiung Lin
Journal:  Int Urogynecol J       Date:  2016-09-08       Impact factor: 2.894

Review 2.  Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.

Authors:  Angamuthu Arunkalaivanan; Hervinder Kaur; Oseka Onuma
Journal:  Int Urogynecol J       Date:  2017-02-02       Impact factor: 2.894

3.  Complications of midurethral slings and their management.

Authors:  Victor W Nitti
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

4.  Structural Reorganization of the Vaginal Mucosa in Stress Urinary Incontinence under Conditions of Er:YAG Laser Treatment.

Authors:  G A Lapii; A Yu Yakovleva; A I Neimark
Journal:  Bull Exp Biol Med       Date:  2017-02-27       Impact factor: 0.804

5.  Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008.

Authors:  Alayne D Markland; Holly E Richter; Chyng-Wen Fwu; Paul Eggers; John W Kusek
Journal:  J Urol       Date:  2011-08       Impact factor: 7.450

Review 6.  Polyacrylamide hydrogel (Bulkamid®) for stress urinary incontinence in women: a systematic review of the literature.

Authors:  Anushuya Devi Kasi; Vasilios Pergialiotis; Despina N Perrea; Azar Khunda; Stergios K Doumouchtsis
Journal:  Int Urogynecol J       Date:  2015-07-26       Impact factor: 2.894

Review 7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.

Authors:  M Gambacciani; M Levancini; M Cervigni
Journal:  Climacteric       Date:  2015-10       Impact factor: 3.005

10.  Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause.

Authors:  Pablo González Isaza; Kinga Jaguszewska; Jose Luis Cardona; Mariusz Lukaszuk
Journal:  Int Urogynecol J       Date:  2017-05-18       Impact factor: 2.894

View more
  2 in total

Review 1.  IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.

Authors:  S Abbas Shobeiri; M H Kerkhof; Vatche A Minassian; Tony Bazi
Journal:  Int Urogynecol J       Date:  2018-12-06       Impact factor: 2.894

2.  Laser treatment in urogynaecology and the myth of the scientific evidence.

Authors:  G Alessandro Digesu; Steven Swift
Journal:  Int Urogynecol J       Date:  2017-08-25       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.